Awareness of Disease Status Among Patients With Cancer: An Integrative Review.


Journal

Cancer nursing
ISSN: 1538-9804
Titre abrégé: Cancer Nurs
Pays: United States
ID NLM: 7805358

Informations de publication

Date de publication:
16 Jan 2023
Historique:
pmc-release: 16 07 2024
entrez: 2 2 2023
pubmed: 3 2 2023
medline: 3 2 2023
Statut: aheadofprint

Résumé

As the quality of cancer care improves, oncology patients face a rapidly increasing number of treatment options. Thus, it is vital that they are full and active partners in the treatment decision-making process. Awareness of disease status has been investigated in the literature; it has been inconsistently conceptualized and operationalized. The aim of this integrative review was to develop a conceptual definition and model of the awareness of disease status among patients with cancer. Whittemore and Knafl's integrative review methodology guided this article. We obtained data through a systematic search of 8 databases. Key terms utilized were awareness, perception, truth disclosure, diagnosis, prognosis, terminal illness, status, neoplasm, and metastasis. Dates through January 2020 were searched to capture all relevant articles. Sixty-nine articles met inclusion criteria. The integrative review methodology guided the development of a conceptual definition and model. The concept of "awareness of disease status" was defined as the individual patient's understanding of being diagnosed and treated for cancer based on the multifactorial components of individual patient characteristics and contextually driven communication practices of healthcare providers. This understanding is dynamic and changes throughout the disease trajectory. These findings will inform consistency in the literature. Such consistency may improve person-centered clinical communication, care planning practices, and, ultimately, cancer-related outcomes. With a greater understanding of the complexity of patients' awareness of disease status, nurses will be able to guide their patients to make informed decisions throughout their disease trajectory.

Sections du résumé

BACKGROUND BACKGROUND
As the quality of cancer care improves, oncology patients face a rapidly increasing number of treatment options. Thus, it is vital that they are full and active partners in the treatment decision-making process. Awareness of disease status has been investigated in the literature; it has been inconsistently conceptualized and operationalized.
OBJECTIVE OBJECTIVE
The aim of this integrative review was to develop a conceptual definition and model of the awareness of disease status among patients with cancer.
METHODS METHODS
Whittemore and Knafl's integrative review methodology guided this article. We obtained data through a systematic search of 8 databases. Key terms utilized were awareness, perception, truth disclosure, diagnosis, prognosis, terminal illness, status, neoplasm, and metastasis. Dates through January 2020 were searched to capture all relevant articles. Sixty-nine articles met inclusion criteria.
RESULTS RESULTS
The integrative review methodology guided the development of a conceptual definition and model. The concept of "awareness of disease status" was defined as the individual patient's understanding of being diagnosed and treated for cancer based on the multifactorial components of individual patient characteristics and contextually driven communication practices of healthcare providers. This understanding is dynamic and changes throughout the disease trajectory.
CONCLUSION CONCLUSIONS
These findings will inform consistency in the literature. Such consistency may improve person-centered clinical communication, care planning practices, and, ultimately, cancer-related outcomes.
IMPLICATIONS FOR PRACTICE CONCLUSIONS
With a greater understanding of the complexity of patients' awareness of disease status, nurses will be able to guide their patients to make informed decisions throughout their disease trajectory.

Identifiants

pubmed: 36728162
doi: 10.1097/NCC.0000000000001170
pii: 00002820-990000000-00091
pmc: PMC10349894
mid: NIHMS1877704
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

A.A. receives support from Blue Note Therapeutics. The other authors have no conflicts of interest to disclose.

Références

J Palliat Med. 2011 Oct;14(10):1104-8
pubmed: 21966988
J Clin Oncol. 2018 Jun 20;36(18):1861-1867
pubmed: 29683788
Support Care Cancer. 2003 Oct;11(10):644-51
pubmed: 12883963
J Palliat Med. 2019 Apr;22(4):377-384
pubmed: 30407108
Br J Cancer. 2003 Aug 18;89(4):641-7
pubmed: 12915871
BMC Health Serv Res. 2022 Jun 17;22(1):786
pubmed: 35715795
Psychosomatics. 2000 Nov-Dec;41(6):500-4
pubmed: 11110113
Iran J Psychiatry Behav Sci. 2015 Dec;9(4):e1792
pubmed: 26834800
J Clin Oncol. 2017 Aug 1;35(22):2551-2557
pubmed: 28574777
Support Care Cancer. 2002 Jan;10(1):51-7
pubmed: 11777189
Tumori. 2000 May-Jun;86(3):199-203
pubmed: 10939598
Qual Life Res. 2006 Apr;15(3):391-404; discussion 405-9
pubmed: 16547776
Int J Nurs Stud. 1985;22(1):33-44
pubmed: 3844383
Psychooncology. 2015 Sep;24(9):1088-96
pubmed: 25707400
Am J Hosp Palliat Care. 2009 Oct-Nov;26(5):384-91
pubmed: 19581384
J Clin Oncol. 2011 Jun 20;29(18):2474-80
pubmed: 21576638
J Health Soc Behav. 1992 Dec;33(4):378-95
pubmed: 1464721
Neuro Oncol. 2017 Oct 19;19(11):1532-1541
pubmed: 28645200
J Clin Oncol. 2016 Jul 10;34(20):2398-403
pubmed: 27217454
Support Care Cancer. 2013 Jul;21(7):1973-81
pubmed: 23430008
J Palliat Med. 2020 Jan;23(1):33-39
pubmed: 31580753
J Pain Symptom Manage. 2006 May;31(5):449-56
pubmed: 16716875
J Palliat Med. 2019 Jul;22(7):782-789
pubmed: 30888907
Palliat Med. 2009 Jun;23(4):354-9
pubmed: 19073780
Palliat Med. 2017 May;31(5):406-418
pubmed: 27492160
Psychooncology. 2017 Nov;26(11):1888-1893
pubmed: 28218982
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Palliat Med. 2006 Feb;9(1):61-9
pubmed: 16430346
Int J Palliat Nurs. 2000 Nov-Dec;6(10):485-94
pubmed: 12271247
J Palliat Med. 2015 Feb;18(2):176-86
pubmed: 25259624
Lung Cancer. 2004 Feb;43(2):175-82
pubmed: 14739038
J Clin Oncol. 2011 Jun 10;29(17):2319-26
pubmed: 21555700
N Engl J Med. 2012 Oct 25;367(17):1616-25
pubmed: 23094723
Support Care Cancer. 2004 Mar;12(3):161-7
pubmed: 14747937
Support Care Cancer. 2007 Feb;15(2):187-96
pubmed: 16953423
Psychooncology. 2006 Jan;15(1):44-55
pubmed: 15750997
J Cancer Educ. 1993 Summer;8(2):141-4
pubmed: 8363941
Psychooncology. 2018 Jan;27(1):106-113
pubmed: 28603876
Psychooncology. 2008 Dec;17(12):1202-9
pubmed: 18521969
BMC Cancer. 2009 Jan 29;9:39
pubmed: 19178719
J Nurs Scholarsh. 2005;37(4):348-53
pubmed: 16396408
Indian J Med Res. 2016 May;143(Supplement):S38-S44
pubmed: 27748276
JAMA. 1998 Jun 3;279(21):1709-14
pubmed: 9624023
Psychooncology. 2011 Mar;20(3):294-301
pubmed: 20238307
Psychooncology. 2016 Apr;25(4):455-62
pubmed: 26283000
J Health Psychol. 2014 Sep;19(9):1103-19
pubmed: 24157936
Palliat Support Care. 2023 Feb;21(1):12-19
pubmed: 35236541
Oncology. 1996 Jul-Aug;53(4):295-302
pubmed: 8692533
Psychooncology. 2013 Dec;22(12):2771-8
pubmed: 23839783
BMC Cancer. 2004 May 19;4:21
pubmed: 15151702
J Clin Oncol. 2015 Nov 10;33(32):3809-16
pubmed: 26438121
J Adv Nurs. 2005 Dec;52(5):546-53
pubmed: 16268861
J Palliat Med. 2006 Dec;9(6):1359-68
pubmed: 17187544
Psychooncology. 2018 Jul;27(7):1765-1771
pubmed: 29611241
J Psychosom Res. 1998 Sep;45(3):257-61
pubmed: 9776371
BMC Palliat Care. 2008 Feb 28;7:2
pubmed: 18307800
Palliat Med. 2002 Jul;16(4):315-21
pubmed: 12132544
Jpn J Clin Oncol. 2013 Sep;43(9):910-6
pubmed: 23894203
J Palliat Med. 2014 Jun;17(6):673-82
pubmed: 24742212
J Palliat Med. 2016 Dec;19(12):1296-1303
pubmed: 27574869
Support Care Cancer. 2005 Nov;13(11):938-42
pubmed: 15800770
Palliat Med. 1999 Jan;13(1):19-35
pubmed: 10320873
J Public Health Med. 2003 Dec;25(4):313-7
pubmed: 14747590
J Adv Pract Oncol. 2021 Mar;12(2):165-172
pubmed: 34109048
Palliat Med. 2013 Feb;27(2):144-54
pubmed: 22143041
Surgeon. 2017 Feb;15(1):12-17
pubmed: 26279202
J Clin Oncol. 2009 Dec 1;27(34):5757-62
pubmed: 19826116
Psychooncology. 2014 Sep;23(9):975-80
pubmed: 24577849
Cancer. 2022 Mar 15;128(6):1339-1345
pubmed: 34787930
Support Care Cancer. 1994 Jul;2(4):242-4
pubmed: 7522106
J Pain Symptom Manage. 2009 Mar;37(3):325-30
pubmed: 18715750
Support Care Cancer. 2012 Jun;20(6):1309-16
pubmed: 21720748
J Cancer Educ. 2014 Jun;29(2):311-7
pubmed: 24402976
J Palliat Med. 2007 Jun;10(3):741-8
pubmed: 17592986
Ann N Y Acad Sci. 1966 Jan 21;125(3):984-94
pubmed: 5223417
Br J Cancer. 1988 Sep;58(3):355-8
pubmed: 2460120
Support Care Cancer. 2008 Sep;16(9):1049-57
pubmed: 18196288
Radiat Med. 1997 Mar-Apr;15(2):133-5
pubmed: 9192442

Auteurs

Catherine S Finlayson (CS)

Author Affiliations: Department of PhD in Nursing, Pace University Lienhard School of Nursing, Pleasantville (Dr Finlayson and Ms Mathew); and Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center (Drs Rosa and Applebaum); New York University Rory Meyers College of Nursing (Dr Squires), New York; and Rutgers, The State University of New Jersey School of Nursing, New Brunswick, New Jersey (Dr Fu).

Classifications MeSH